You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 30, 2023

Hikma Intl Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HIKMA INTL PHARMS, and when can generic versions of HIKMA INTL PHARMS drugs launch?

HIKMA INTL PHARMS has forty-five approved drugs.

There are five US patents protecting HIKMA INTL PHARMS drugs.

Summary for Hikma Intl Pharms

US Patents:	5
Tradenames:	33
Ingredients:	32
NDAs:	45

Drugs and US Patents for Hikma Intl Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	DOPAMINE HYDROCHLORIDE	dopamine hydrochloride	INJECTABLE;INJECTION	207707-001	Apr 11, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hikma Intl Pharms	ISOSORBIDE DINITRATE	isosorbide dinitrate	TABLET;ORAL	086067-001	Oct 29, 1987	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hikma Intl Pharms	LISINOPRIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; lisinopril	TABLET;ORAL	076265-001	Jul 8, 2002		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Hikma Intl Pharms	BUTALBITAL, ASPIRIN AND CAFFEINE	aspirin; butalbital; caffeine	TABLET;ORAL	086162-002	Feb 16, 1984		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Hikma Intl Pharms	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	206617-002	Jun 25, 2021	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hikma Intl Pharms	RESERPINE	reserpine	TABLET;ORAL	080975-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HIKMA INTL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	0.6 mg	➤ Subscribe	2016-06-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

McKinsey

Johnson and Johnson

Moodys

Boehringer Ingelheim

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.